The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period
We describe the immediate- and longer-term direct medical costs of care for individuals diagnosed with HIV at CD4 counts <350/mm3 (“late presenters”). We collected and stratified by initial CD4 count all inpatient, outpatient, and drug costs for all newly diagnosed patients accessing HIV care wit...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | AIDS Research and Treatment |
| Online Access: | http://dx.doi.org/10.1155/2012/757135 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850105219575185408 |
|---|---|
| author | Hartmut B. Krentz M. John Gill |
| author_facet | Hartmut B. Krentz M. John Gill |
| author_sort | Hartmut B. Krentz |
| collection | DOAJ |
| description | We describe the immediate- and longer-term direct medical costs of care for individuals diagnosed with HIV at CD4 counts <350/mm3 (“late presenters”). We collected and stratified by initial CD4 count all inpatient, outpatient, and drug costs for all newly diagnosed patients accessing HIV care within Southern Alberta from 1/1/1995 to 1/1/2010. 59% of new patients were late presenters. We found significantly higher costs for late presenters, especially inpatient costs, during the first year after accessing care. Direct medical costs remained almost twice as high for late presenters in subsequent years compared to patients presenting with CD4 counts >350/mm3 despite significantly their improved CD4 counts. The sustained high cost for late presenters has implications for recent recommendations for wider routine HIV testing and the earlier initiation of cART. Earlier diagnosis and treatment, while increasing the immediate expenditures within a population, may produce both direct and indirect cost savings in the longer term. |
| format | Article |
| id | doaj-art-3d4b2d391afc47a7a5df2ee979b825a2 |
| institution | OA Journals |
| issn | 2090-1240 2090-1259 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | AIDS Research and Treatment |
| spelling | doaj-art-3d4b2d391afc47a7a5df2ee979b825a22025-08-20T02:39:09ZengWileyAIDS Research and Treatment2090-12402090-12592012-01-01201210.1155/2012/757135757135The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year PeriodHartmut B. Krentz0M. John Gill1Southern Alberta Clinic, Sheldon M Chumir Health Centre, No. 3223, 1213-4th St SW, Calgary, AB, T2R 0X7, CanadaSouthern Alberta Clinic, Sheldon M Chumir Health Centre, No. 3223, 1213-4th St SW, Calgary, AB, T2R 0X7, CanadaWe describe the immediate- and longer-term direct medical costs of care for individuals diagnosed with HIV at CD4 counts <350/mm3 (“late presenters”). We collected and stratified by initial CD4 count all inpatient, outpatient, and drug costs for all newly diagnosed patients accessing HIV care within Southern Alberta from 1/1/1995 to 1/1/2010. 59% of new patients were late presenters. We found significantly higher costs for late presenters, especially inpatient costs, during the first year after accessing care. Direct medical costs remained almost twice as high for late presenters in subsequent years compared to patients presenting with CD4 counts >350/mm3 despite significantly their improved CD4 counts. The sustained high cost for late presenters has implications for recent recommendations for wider routine HIV testing and the earlier initiation of cART. Earlier diagnosis and treatment, while increasing the immediate expenditures within a population, may produce both direct and indirect cost savings in the longer term.http://dx.doi.org/10.1155/2012/757135 |
| spellingShingle | Hartmut B. Krentz M. John Gill The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period AIDS Research and Treatment |
| title | The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period |
| title_full | The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period |
| title_fullStr | The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period |
| title_full_unstemmed | The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period |
| title_short | The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period |
| title_sort | direct medical costs of late presentation 350 mm3 of hiv infection over a 15 year period |
| url | http://dx.doi.org/10.1155/2012/757135 |
| work_keys_str_mv | AT hartmutbkrentz thedirectmedicalcostsoflatepresentation350mm3ofhivinfectionovera15yearperiod AT mjohngill thedirectmedicalcostsoflatepresentation350mm3ofhivinfectionovera15yearperiod AT hartmutbkrentz directmedicalcostsoflatepresentation350mm3ofhivinfectionovera15yearperiod AT mjohngill directmedicalcostsoflatepresentation350mm3ofhivinfectionovera15yearperiod |